当前位置: X-MOL 学术Antivir. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Pimodivir treatment in adult volunteers experimentally inoculated with live influenza virus: a Phase IIa, randomized, double-blind, placebo-controlled study.
Antiviral Therapy ( IF 1.3 ) Pub Date : 2017-12-16 , DOI: 10.3851/imp3212
Jose M Trevejo 1 , Mohammed Asmal 2 , Johan Vingerhoets 3 , Ramon Polo 4 , Sarah Robertson 5 , Ying Jiang 6 , Tara L Kieffer 5 , Lorant Leopold 4
Affiliation  

Pimodivir (formerly JNJ-63623872) is a novel, non-nucleoside polymerase complex inhibitor with in vitro activity against influenza A virus, including pandemic 2009 H1N1, H7N9, H5N1 strains as well as neuraminidase- and amantadine-resistant strains.

中文翻译:

在实验中用活流感病毒接种成年志愿者的匹莫地韦治疗:IIa期,随机,双盲,安慰剂对照研究。

Pimodivir(以前称为JNJ-63623872)是一种新型的非核苷聚合酶复合物抑制剂,具有体外抗A型流感病毒的活性,包括大流行的2009 H1N1,H7N9,H5N1菌株以及耐神经氨酸酶和金刚烷胺的菌株。
更新日期:2020-08-21
down
wechat
bug